by Isogenica Webmaster | Sep 2019 | Press Releases, Welcome
Isogenica appoints Dr David Mead as Director of Business Development Isogenica today announced the appointment of Dr David Mead as Director of Business Development effective immediately. Dr Mead was previously Business Development Director at Albumedix where he was...
by Isogenica Webmaster | Jan 2019 | Press Releases, Welcome
Isogenica expands collaboration with Aro Biotherapeutics Isogenica today announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics in June 2018. Under the expanded agreement, Isogenica will use its CIS Display platform to help...
by Isogenica Webmaster | Sep 2018 | Press Releases, Welcome
Isogenica appoints Dr Emma Sceats as Chief Executive Officer Isogenica Ltd, a leader in the design and construction of diverse, fully synthetic, antibody libraries for biopharmaceutical discovery, today announced that Dr Emma Sceats has been appointed Chief Executive...
by Isogenica Webmaster | Apr 2018 | Press Releases, Welcome
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology. Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers. Isogenica Ltd and Fusion...
